Inflammatory mediators in inflammatory bowel disease
Iris Dotan, Daniel Rachmilewitz
Abstract
Iris Dotan, Daniel Rachmilewitz
Abstract
Research this year concentrated on defining the role of inflamatory mediators and their modulation in the treatment of inflammatory bowel disease and experimental colitis. Whereas leukotriene B4 blockade was found to have no effect on ulcerative colitis, blockade of thromboxane A2, the inducible nitric oxide synthase, and elimination of oxygen radicals seemed efficacious in animal models. Interest in nitric oxide and oxygen free radicals increased, demonstrating the deleterious effect these molecules have on intestinal inflammation.
OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Research this year concentrated on defining the role of inflamatory mediators and their modulation in the treatment of inflammatory bowel disease and experimental colitis. Whereas leukotriene B4 blockade was found to have no effect on ulcerative colitis, blockade of thromboxane A2, the inducible nitric oxide synthase, and elimination of oxygen radicals seemed efficacious in animal models. Interest in nitric oxide and oxygen free radicals increased, demonstrating the deleterious effect these molecules have on intestinal inflammation.
Key concepts: Inflammatory bowel disease, Nitric oxide, Ulcerative colitis, Blockade, Inflammation, Nitric oxide synthase, Leukotriene B4, Colitis